Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.
Stacker on MSN
New anxiety medications are in the pipeline for 2026
LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...
Mind Medicine (MindMed) Inc. achieved positive results from phase 2b MMED008 study using MM-120 for the treatment of patients with generalized anxiety disorder. End-of-phase 2 meeting with the FDA for ...
The device is designed to transcutaneously deliver low-level electrical stimulation to the skin behind the ears. The Food and Drug Administration (FDA) has cleared Modius Stress, a transdermal, ...
In a world of constant connectivity and mounting pressures, generalized anxiety disorder (GAD) has emerged as a significant mental health challenge affecting millions. Recent studies show that anxiety ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PsiGAD psilocybin-assisted therapy demonstrated a ...
The Food and Drug Administration has granted the company’s LSD treatment for generalized anxiety disorder a “breakthrough therapy” status. A single oral administration of 100 micrograms MM120 in ...
Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric ...
Smartphone-based cognitive-behavioral therapy outperforms psychoeducation for generalized anxiety disorder, with benefits ...
Some anxiety is part of the cost of admission to humanity. Because its distinguishing raison d’etre is the anticipation of bad outcomes, it can be a helpful stimulus to preparation or rehearsal before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback